Posts

Showing posts with the label Biobanking Industry Data Book

Biobanking Industry Is Driven By Growing Investments For R&D Of Advanced Therapies Along With Cancer Genomic

Image
      Biobanking Industry Data Book Covers Biobanks, Cell Banking Outsourcing, Cord Blood Banking Services, DNA & RNA Banking Services Markets. Biobanks market was valued at USD 66.06 Billion in 2021 with CAGR of 4.6% during 2022-2030. Cell banking outsourcing market projected to grow at the CAGR of 16.39%. Biobanks and biorepositories provide biological resources that aid in effective translation of biomedical research.   Access the Global Biobanking Industry Data Book, 2023 to 2030 , compiled with details like market sizing information & forecasts, trade data, pricing intelligence, competitive benchmarking, macro-environmental analyses, and regulatory & technological framework studies.   Biobanks Market Growth & Trends The global biobanks market size is expected to reach USD 136.9 billion by 2030, according to a new report by Grand View Research, Inc., registering a CAGR of 8.6% during the forecast period. Biobanks continue to evolve with the i...

Biobanking Industry Will Rise Due To Growing Investments For R&D Of Advanced Therapies

The global biobanking industry size will witness an upward growth trajectory in the wake of soaring investments in regenerative medicine and personalized medicine, according to the " Biobanking Industry Data Book, 2023 - 2030 ," published by Grand View Research. The growing commercialization of biobanking services and the rising penetration of novel therapeutic discovery have opened avenues of growth for pharmaceutical and biotechnology researchers. Biobanks have become invaluable for drug discovery and assessing the genetic component of human disease, a trend likely to expand to the realms of virtual biobanks, blood banks, DNA/RNA banks, genetic banks and stem cell banks. The demand for medical data sets in biobanks has spurred the trend for precision medicine. A personalized approach to healthcare, as well as the development of new drugs, has become paramount. So much so that the identification of biomarkers has gained an impetus for early detection, treatment and preventio...